1.- Schutte K,
Bornschein J,
Malfertheiner P.
Hepatocellular carcinoma— epidemiological trends and risk factors.
Dig Dis 2009; 27:80–92.
2.- Gaba RC,
Lokken RP,
Hickey RM,
Lipnik AJ,
Lewandowski RJ,
Salem R,
Brown DB,
Walker TG,
Silberzweig JE,
Baerlocher MO,
Echenique AM,
Midia M,
Mitchell JW,
Padia SA,
Ganguli S,
Ward TJ,
Weinstein JL,
Nikolic B,
Dariushnia SR; Society of Interventional Radiology Standards of Practice Committee.
Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. J Vasc Interv Radiol.
2017;28:1210-1223.e3.
3.- Ding J,
Jing X,
Wang Y,
Wang F,
Wang Y,
Du Z.
Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol 2016;71:1270-1276.
4.- Zheng RN,
You ZJ,
Lin SH,
Jia J,
Cai YM,
Liu C,
et al.
Efficacy of percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma. Genet Mol Res 2015;14:17982-17994.
5.- Morales AS,
Aldana C,
Martinez,
R,
Perez J.
Experience in radiofrequency ablation of hepatic focal lesions in a fourth-level institution.
Poster presented at: European Congress of Radiology; February 28,
2018; Vienna,
Austria.